switching between glp 1 agonists Glucagon-Like Peptide-1 Receptor Agonists: Rationale and Practical Guidance Science's 2023 Breakthrough: GLP-1R Agonists

Carnitine status of pediatric patients on continuous ambulatory peritoneal dialysis

Models explore pulsatile GH-axis dynamics, second-messenger responses, and combinatorial pathway effects in vitro

2.5 NK cells NK cells, as member of the innate immune system, can interact directly or indirectly with other immune cells and participate in RA progress

Methyl--butyrobetaine decreases levels of acylcarnitines and attenuates the development of atherosclerosis

Among them, agomelatine (S20098, N-[2-(7-methoxynaphth-1-yl)ethyl]acetamide) first reported in 1992, is by far the best studied

In recent years, peptide-based drugs and biohacking compounds have surged in popularity for their ability to target specific receptors with fewer side effects than traditional drugs